Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LABP - Landos Biopharma appoints Fabio Cataldi as Chief Medical Officer


LABP - Landos Biopharma appoints Fabio Cataldi as Chief Medical Officer

  • Landos Biopharma ( NASDAQ: LABP ) has appointed Fabio Cataldi, MD, as the company’s Chief Medical Officer, effective September 5, 2022.
  • Most recently, Dr. Cataldi served as Arena’s Vice President and Therapeutic Area Head Gastroenterology, where he helped lead the development of etrasimod, until its sale to Pfizer for nearly $7B.

For further details see:

Landos Biopharma appoints Fabio Cataldi as Chief Medical Officer
Stock Information

Company Name: Landos Biopharma Inc.
Stock Symbol: LABP
Market: NASDAQ
Website: landosbiopharma.com

Menu

LABP LABP Quote LABP Short LABP News LABP Articles LABP Message Board
Get LABP Alerts

News, Short Squeeze, Breakout and More Instantly...